Skip to content
Open access

Non-neutralizing antibody responses control acute Crimean-Congo hemorrhagic fever virus infection in naïve mice

Sep 2026 · Journal of Virology · Vol 100 · 0 citations · 38 references
Medicine

TL;DR

A mouse-adapted strain of CCHFV (MA-CCHFV) is used to investigate the requirement of humoral immunity in control of acute CCHFV infection in naive immunocompetent mice and finds that mice develop a rapid, non-neutralizing antibody response that is crucial for control of the acute infection.

Abstract

ABSTRACT Crimean-Congo hemorrhagic fever virus (CCHFV) is the cause of a sometimes-severe viral hemorrhagic fever, CCHF. Severe cases of CCHF often have little-to-no CCHFV-specific antibody responses prior to death. However, it is unclear if the failure to mount an antibody response is the cause of a poor outcome or a correlate of a failed host response. Here, we used a mouse-adapted strain of CCHFV (MA-CCHFV) to investigate the requirement of humoral immunity in control of acute CCHFV infection in immunocompetent mice. We found that mice infected with MA-CCHFV develop a rapid non-neutralizing antibody response, consistent with humans infected with CCHFV. Further, we found that the absence of humoral immunity in male but not female mice resulted in near-uniform mortality. Lastly, we determined that complement but not activating Fc-receptors nor the cytoplasmic Fc-receptor tripartite motif containing protein 21 contributed to antibody-mediated control of MA-CCHFV infection. Together, our findings identify rapid humoral immune responses as a critical component of the host response to acute CCHFV infection in naive hosts. IMPORTANCE Crimean-Congo hemorrhagic fever virus (CCHFV) is the cause of a serious viral hemorrhagic fever in humans. Severe disease and poor outcomes are correlated with little-to-no CCHFV-specific antibody. However, it is unknown if the lack of CCHFV-specific antibody is a direct cause or merely a correlate of a poor outcome. Here, we investigated the contribution of humoral immunity in control of acute CCHFV infection in naive immunocompetent mice. We found that mice develop a rapid, non-neutralizing antibody response that is crucial for control of the acute infection. Further, we found that loss of complement but not activating Fc receptors or the cytoplasmic Fc receptor TRIM21 worsened disease. Together, our findings suggest that lack of CCHFV-specific antibody responses may directly contribute to poor outcomes in CCHFV-infected humans. Crimean-Congo hemorrhagic fever virus (CCHFV) is the cause of a serious viral hemorrhagic fever in humans. Severe disease and poor outcomes are correlated with little-to-no CCHFV-specific antibody. However, it is unknown if the lack of CCHFV-specific antibody is a direct cause or merely a correlate of a poor outcome. Here, we investigated the contribution of humoral immunity in control of acute CCHFV infection in naive immunocompetent mice. We found that mice develop a rapid, non-neutralizing antibody response that is crucial for control of the acute infection. Further, we found that loss of complement but not activating Fc receptors or the cytoplasmic Fc receptor TRIM21 worsened disease. Together, our findings suggest that lack of CCHFV-specific antibody responses may directly contribute to poor outcomes in CCHFV-infected humans.

Read PDF

Similar papers

Open access Sep 2026

Lethal Sudan virus infection in IFNAR-/- mice is characterized by key inflammatory features of filovirus disease

The observed cytokine and chemokine elevations are consistent with inflammatory responses described in filovirus infections, although the single terminal sampling time point and limited cohort size preclude conclusions regarding the temporal development or mechanistic basis of this response.

Michelle Gellhorn Serra, Cornelius Rohde, Lucie Sauerhering et al. · 0 citations
Open access Oct 2026

Dual-Antigen CCHFV Vaccine Induces Neutralizing Immunity and Protection Against Lethal Challenge

It is demonstrated that systematic antigen screening combined with genetic vaccine platforms can identify a potent multi-antigen CCHF vaccine candidate and induced Gc-specific neutralizing antibodies and T-cell responses against both NP and Gc.

Jing-Yi Yan, Lara Sweetapple, Christian An Bính Nordentoft et al. · 0 citations
Open access Sep 2026

Crimean-Congo Hemorrhagic Fever Without Hemorrhagic Manifestations: A Case Report

Background: Crimean-Congo hemorrhagic fever (CCHF) is a potentially life-threatening viral infection caused by Crimean-Congo hemorrhagic fever virus (CCHFV). The virus is primarily transmitted through the bite of infected Hyalomma ticks or through contact with the blood or tissues of infected animals, particularly duri...

Hisham Eltayeb Ahmed Elhassan, Syed Majid Hamid, Fathelrahman Ahmed · 0 citations
Open access Oct 2026

Protective mechanisms against murine coronavirus infection in individual mice and its transmission between mice.

Murine coronavirus, commonly known as mouse hepatitis virus (MHV), is a representative pathogenic virus in mice. MHV infection in mice is used as a model for viral infections and is utilized to analyze the mechanisms of protection and transmission. By establishing MHV-specific T cell clones and conducting adoptive tran...

Shigeru Kyuwa · 0 citations
Open access Sep 2026

Kinetics and specificity of orthoflaviviruses NS1 IgG after Zika virus infection in Yellow fever and dengue immunized individuals: a memory recall hypothesis

Pre-existing Orthoflavivirus immunity can shape antibody recall upon infection with a heterologous virus. We monitored Zika virus (ZIKV) infection in individuals vaccinated against yellow fever virus (YFV), with or without prior dengue virus (DENV) exposure. We obtained longitudinal serology data (NS1- and whole-virus...

S. Marquine, N. Ayhan, K. M. Meneyrol et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.